ATE215987T1 - Hepatitis-b-virus-oberflächenproteine mit reduziertem gehalt an wirtkohlenwasserstoffen - Google Patents

Hepatitis-b-virus-oberflächenproteine mit reduziertem gehalt an wirtkohlenwasserstoffen

Info

Publication number
ATE215987T1
ATE215987T1 AT92303883T AT92303883T ATE215987T1 AT E215987 T1 ATE215987 T1 AT E215987T1 AT 92303883 T AT92303883 T AT 92303883T AT 92303883 T AT92303883 T AT 92303883T AT E215987 T1 ATE215987 T1 AT E215987T1
Authority
AT
Austria
Prior art keywords
hbv
surface proteins
hepatitis
particles
substantially reduced
Prior art date
Application number
AT92303883T
Other languages
English (en)
Inventor
Peter J Kniskern
Arpi Hagopian
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE215987T1 publication Critical patent/ATE215987T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
AT92303883T 1991-04-29 1992-04-29 Hepatitis-b-virus-oberflächenproteine mit reduziertem gehalt an wirtkohlenwasserstoffen ATE215987T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69292491A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
ATE215987T1 true ATE215987T1 (de) 2002-04-15

Family

ID=24782605

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303883T ATE215987T1 (de) 1991-04-29 1992-04-29 Hepatitis-b-virus-oberflächenproteine mit reduziertem gehalt an wirtkohlenwasserstoffen

Country Status (25)

Country Link
US (1) US5614384A (de)
EP (1) EP0516286B1 (de)
JP (1) JP2637877B2 (de)
KR (1) KR920019373A (de)
CN (1) CN1067680A (de)
AT (1) ATE215987T1 (de)
AU (1) AU650530B2 (de)
BG (1) BG61700B1 (de)
CA (1) CA2067290A1 (de)
CZ (1) CZ282769B6 (de)
DE (1) DE69232541D1 (de)
FI (1) FI934650A7 (de)
HU (1) HUT69149A (de)
IE (1) IE921385A1 (de)
IL (1) IL101651A0 (de)
LT (1) LT3367B (de)
MX (1) MX9201970A (de)
NO (1) NO933897L (de)
NZ (1) NZ242487A (de)
PL (1) PL171485B1 (de)
SG (1) SG55152A1 (de)
SK (1) SK118193A3 (de)
WO (1) WO1992019741A1 (de)
YU (1) YU45492A (de)
ZA (1) ZA923069B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
WO1995031558A1 (en) * 1994-05-16 1995-11-23 Merck & Co., Inc. Process for producing hbv surface proteins
US6300065B1 (en) * 1996-05-31 2001-10-09 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
AU2212100A (en) * 1998-12-23 2000-07-12 Merck & Co., Inc. Improved recombinant hepatitis b surface antigen
KR100604994B1 (ko) 2004-01-30 2006-07-26 한국생명공학연구원 알파1,6-만노실트랜스퍼라제를 코딩하는 한세눌라폴리모르파 기원의 신규 유전자 및 상기 유전자가 결손된한세눌라 폴리모르파 변이주를 이용한 재조합 당단백질생산 방법
CN111187720A (zh) * 2019-12-27 2020-05-22 深圳康泰生物制品股份有限公司 表达肠道病毒71型抗原的重组汉逊酵母的细胞破碎方法及其在制备手足口病疫苗中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
GB8613388D0 (en) * 1986-06-03 1986-07-09 Delta Biotechnology Ltd Induction of galactose regulated gene expression in yeast
DE3719213C1 (de) * 1987-06-09 1988-05-19 Daimler Benz Ag Bodennahe mehrpolige Stromversorgung fuer spurfuehrbare,gummibereifte,elektrisch antreibbare Fahrzeuge
US4963483A (en) * 1987-10-13 1990-10-16 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
US5135854A (en) * 1987-10-29 1992-08-04 Zymogenetics, Inc. Methods of regulating protein glycosylation
ATE100142T1 (de) * 1987-10-29 1994-01-15 Zymogenetics Inc Verfahren zur regulierung der proteinglycosylierung.
GB8726953D0 (en) * 1987-11-18 1987-12-23 Delta Biotechnology Ltd Yeast expression system
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
EP0414374B1 (de) * 1989-07-25 1997-10-08 Smithkline Biologicals S.A. Antigene sowie Verfahren zu deren Herstellung
CA2022109A1 (en) * 1989-07-31 1991-02-01 Cheryl A. Schulman Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media
CA2022108A1 (en) * 1989-07-31 1991-02-01 Cheryl A. Schulman Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis
DE69013471T2 (de) * 1989-12-05 1995-03-30 Merck & Co Inc Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles

Also Published As

Publication number Publication date
MX9201970A (es) 1992-11-01
CA2067290A1 (en) 1992-10-30
CZ227193A3 (en) 1994-04-13
SG55152A1 (en) 1998-12-21
SK118193A3 (en) 1994-03-09
WO1992019741A1 (en) 1992-11-12
NO933897D0 (no) 1993-10-28
HUT69149A (en) 1995-08-28
IE921385A1 (en) 1992-11-04
CZ282769B6 (cs) 1997-10-15
ZA923069B (en) 1992-12-30
CN1067680A (zh) 1993-01-06
EP0516286A1 (de) 1992-12-02
HU9303064D0 (en) 1994-03-28
LT3367B (en) 1995-08-25
BG61700B1 (bg) 1998-03-31
PL171485B1 (pl) 1997-05-30
FI934650A0 (fi) 1993-10-21
NZ242487A (en) 1994-07-26
JP2637877B2 (ja) 1997-08-06
BG98187A (bg) 1994-06-30
FI934650A7 (fi) 1993-10-21
AU1522292A (en) 1993-03-11
LTIP462A (en) 1994-10-25
DE69232541D1 (de) 2002-05-16
YU45492A (sh) 1994-06-10
KR920019373A (ko) 1992-11-19
JPH06141872A (ja) 1994-05-24
NO933897L (no) 1993-10-28
AU650530B2 (en) 1994-06-23
EP0516286B1 (de) 2002-04-10
US5614384A (en) 1997-03-25
IL101651A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DE122007000028I1 (de) Sich selbst-zusammenbauende Rekombinante HPV16 Papillomavirus Hüllproteine
WO1993014208A3 (en) Hepatitis e virus vaccine and method
DE69232541D1 (de) Hepatitis-B-Virus-Oberflächenproteine mit reduziertem Gehalt an Wirtkohlenwasserstoffen
YU45292A (sh) Različiti površinski proteini hepatitis b virusa koji obrazuju čestice
DE69333057D1 (de) Rekombinente Adenoviren-Impfstoffe
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ATE241385T1 (de) Rekombinante adenovirus-vakzinen
EP0344864A3 (de) Verfahren zur Herstellung von nicht-hyperglycosylierten Hepatitis B Virusproteinen
NZ295056A (en) Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines
CA2105277A1 (en) Genetically engineered vaccine strain
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
RU93058279A (ru) Система экспрессии, белок, вакцина, реагент
EP0288198A3 (de) Peptidherstellung
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
EP0485347A3 (en) Recombinant hepatitis delta antigen, process for the purification and use thereof
EP0503252A3 (en) Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines
CA2558659A1 (en) Genetically engineered canary poxvirus-based vaccine strain